Pandemic pushes Optegra into deeper EBITDA loss

The Covid-19 pandemic pushed eye care specialist Optegra into deeper EBITDA losses in the year ended 30 June 2020, despite revenue growth of 10% in the first eight months of the year. The halting of elective surgery, along with participation in the nationwide NHS contract, helped push revenue down from £40.2m in 2019 to £34.8m for FY2020….

You must be a HM Subscriber to view this content.

Subscribe Now »